Less Ads, More Data, More Tools Register for FREE

Pin to quick picksCheckit Regulatory News (CKT)

Share Price Information for Checkit (CKT)

Share Price is delayed by 15 minutes
Get Live Data
25.00    0.00 (0.00%)
Bid:
24.00
Ask:
26.00
Spread: 2.00 (8.333%)
Market Cap: £27.00m
CKT Live PriceLast checked at - London Stock Exchange

Intraday Checkit Share Chart

Trading Statement

19 Aug 2009 07:00

RNS Number : 6430X
Elektron PLC
19 August 2009
 

Elektron PLC 19 August 2009

TRADING UPDATE: HALF YEAR ENDED 31 JULY 2009

First Half Results In our last annual report, we stated that we are no longer seeing dramatic declines in our business, and that some areas are seeing improvements. We are pleased to confirm that this continues to be the case. Group sales in the six months to 31 July 2009 were approximately £14 million, while operating profits were slightly higher than internal budgets as a result of continuing actions taken to realign the cost base which started last year.

  At Elektron Components ("ECD"), (our largest division which accounts for approximately 60% of group turnover), sales in the six months to 31 July 2009 were in line with internal budgets. However, gross margins increased as a result of lower material and labour costs, resulting in a substantially improved operating profit above internal forecasts and in line with the first half of last year.

Hard Metal Division ("HMD") sales, which account for approximately 20% of group turnover, were however lower than expected following continuing weak activity in the oil and gas markets served by Total Carbide and the division has continued to operate at a loss. However, market share has been maintained and cost cutting measures continue to be implemented in order to minimise losses. As HMD is a late cycle business, it is expected to see a sharp swing back into profit when market conditions improve.

Elektron Instruments Division ("EID"), which accounts for approximately 20% of group turnover, suffered continued sales weakness but gross margins have held reasonably firm. This division is being restructured, with the manufacture of Sifam brand control knobs and meters being transferred to ECD's China factory and Indian subcontractors. This will leave EID focusing on Digitron temperature and pressure monitoring systems, together with Queensgate, the nanomeasurement company.

Second Half Outlook

Although monthly order intake has been inconsistent, July saw a significant increase at ECD. While it is difficult to accurately predict what may happen in the second half, the Board currently expects that the Group will trade profitably over the full year at the operating level before remaining restructuring costs and is confident that the plans in place will deliver long-term profit and dividend growth.

For further information, please contact: Keith Daley Elektron Plc Tel: 0208 348 0810 Charles Cunningham FinnCap Tel: 0207 600 1658 Cautionary Note This announcement contains certain forward-looking statements that have been made by the Directors in good faith using information available up until the date they approved the statement. Forward-looking statements should be regarded with caution as by their nature such statements involve risk and uncertainties relating to events and circumstances that may occur in the future. Actual results may differ from those expressed in such statements, depending on the outcome of these uncertain future events.

This information is provided by RNS
The company news service from the London Stock Exchange
 
END
 
 
TSTEALPPFLDNEFE
Date   Source Headline
10th Aug 20237:00 amRNSTrading update notice of results & contract
8th Jun 20234:08 pmRNSResult of AGM
24th May 20233:29 pmRNSDirector/PDMR Shareholding
15th May 20231:04 pmRNSPosting of Annual Report and Notice of AGM
24th Apr 20237:00 amRNSPreliminary Results
13th Apr 20231:36 pmRNSNotice of Results and Investor Presentation
23rd Mar 20235:25 pmRNSDirector/PDMR Shareholding
13th Mar 20238:55 amRNSStatement re. Silicon Valley Bank
16th Feb 20237:00 amRNSTrading Update and Notice of Results
26th Jan 20234:10 pmRNSDirectorate Change
23rd Jan 20237:00 amRNSDirector/PCA Dealing
10th Jan 20237:00 amRNSAppointment of Non-Executive Director
10th Jan 20237:00 amRNSGrant of options and PDMR dealings
5th Jan 20237:00 amRNSContract wins and investor presentation
12th Dec 20225:14 pmRNSDirector/PDMR Shareholding
27th Sep 202212:28 pmRNSHolding(s) in Company
23rd Sep 20226:16 pmRNSDirector/PDMR Shareholding
16th Sep 20225:36 pmRNSDirector Dealing
15th Sep 20227:00 amRNSInterim Results
6th Sep 20227:00 amRNSInvestor Presentation
22nd Aug 20221:07 pmRNSDirector/PDMR Shareholding
11th Aug 20227:00 amRNSTrading Update and Notice of Interim Results
9th Jun 20223:09 pmRNSResult of AGM
13th May 20225:17 pmRNSPosting of Annual Report and Notice of AGM
13th May 20227:00 amRNSInvestor Conference
4th May 20227:00 amRNSContract Renewal
28th Apr 20227:00 amRNSPreliminary Results
29th Mar 20227:00 amRNSGrant of options and PDMR dealings
23rd Feb 20227:00 amRNSPDMR Dealing
22nd Feb 20227:00 amRNSPDMR Dealing
17th Feb 20227:00 amRNSTrading update
1st Feb 20227:00 amRNSContract win
22nd Dec 20212:06 pmRNSHolding(s) in Company
20th Dec 20217:01 amEQSCheckit (CKT): SaaS software for the deskless workforce
17th Dec 20212:44 pmRNSDirector/PDMR Shareholding
16th Dec 202111:52 amRNSResult of General Meeting and Admission
2nd Dec 202111:00 amRNSHolding(s) in Company
2nd Dec 202111:00 amRNSHolding(s) in Company
29th Nov 202111:44 amRNSPosting of Circular and Notice of General Meeting
26th Nov 20212:23 pmRNSResult of Placing
26th Nov 20217:00 amRNSProposed Placing
28th Oct 20217:00 amRNSContract win
16th Sep 20217:00 amRNSInterim Results
12th Aug 20217:00 amRNSTrading Update and Notice of Interim Results
6th Aug 20213:13 pmRNSDirector/PDMR Shareholding
15th Jul 20217:00 amRNSProduct Update
13th Jul 20215:08 pmRNSGrant of options and PDMR dealings
12th Jul 20217:00 amRNSAppointment of Chief Executive Officer
29th Jun 20214:01 pmRNSCapital Markets Day
10th Jun 20219:16 amRNSPDMR Dealing

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.